Gemma CEO Collins of Argan (NYSE: AGX) sells 13,568 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ARGAN INC executive Charles Edwin Collins IV, CEO of Gemma, reported option exercises and share sales in April 2026. He exercised stock options to acquire a total of 13,568 shares of common stock at exercise prices ranging from $33.81 to $148.72 per share.
On April 20, 2026, he exercised an option for 2,500 shares at $39.47 per share and sold 2,500 shares at $610 per share. On April 21, 2026, he exercised additional options totaling 11,068 shares and sold 11,068 shares at an average price of $621.61 per share. Following these transactions, he directly holds 30,320 shares of ARGAN common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 13,568 shares ($8,404,979)
Net Sell
12 txns
Insider
Collins Charles Edwin IV
Role
CHIEF EXECUTIVE OFFICER, GEMMA
Sold
13,568 shs ($8.40M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock | 5,000 | $36.78 | $184K |
| Exercise | Option to Purchase Common Stock | 5,235 | $33.81 | $177K |
| Exercise | Option to Purchase Common Stock | 500 | $61.22 | $31K |
| Exercise | Option to Purchase Common Stock | 333 | $148.72 | $50K |
| Exercise | Common Stock | 5,000 | $36.78 | $184K |
| Exercise | Common Stock | 5,235 | $33.81 | $177K |
| Exercise | Common Stock | 500 | $61.22 | $31K |
| Exercise | Common Stock | 333 | $148.72 | $50K |
| Sale | Common Stock | 11,068 | $621.61 | $6.88M |
| Exercise | Option to Purchase Common Stock | 2,500 | $39.47 | $99K |
| Exercise | Common Stock | 2,500 | $39.47 | $99K |
| Sale | Common Stock | 2,500 | $610.00 | $1.52M |
Holdings After Transaction:
Option to Purchase Common Stock — 7,567 shares (Direct, null);
Common Stock — 35,320 shares (Direct, null)
Footnotes (1)
- On April 20, 2026, the Reporting Person exercised his stock option awarded on April 17, 2023 to purchase 2,500 shares of the Issuer's common stock at a price of $39.47 per share. On April 20, 2026, the Reporting Person sold 2,500 shares of the Issuer's common stock on the open market at a price of $610 per share. On April 21, 2026, the Reporting Person exercised his stock option awarded on April 18, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $36.78 per share. On April 21, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 16, 2020 to purchase 5,235 shares of the Issuer's common stock at a price of $33.81 per share. On April 21, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 500 shares of the Issuer's common stock at a price of $61.22 per share. On April 21, 2026, the Reporting Person exercised a portion of his stock option awarded on April 10, 2025 to purchase 333 shares of the Issuer's common stock at a price of $148.72 per share. On April 21, 2026, the Reporting Person sold 11,068 shares of the Issuer's common stock on the open market at an average price of $621.61 per share.
Key Figures
Total shares sold: 13,568 shares
Sale price April 20, 2026: $610 per share
Average sale price April 21, 2026: $621.61 per share
+4 more
7 metrics
Total shares sold
13,568 shares
Open-market sales on April 20–21, 2026
Sale price April 20, 2026
$610 per share
2,500 common shares sold in open market
Average sale price April 21, 2026
$621.61 per share
11,068 common shares sold in open market
Options exercised total shares
13,568 shares
Common stock acquired via option exercises
Example exercise price
$39.47 per share
2,500-share stock option exercised April 20, 2026
Highest exercise price
$148.72 per share
333-share stock option exercised April 21, 2026
Post-transaction holdings
30,320 shares
Direct common stock owned after April 2026 trades
Key Terms
open-market sale, stock option, derivative security, Option to Purchase Common Stock, +1 more
5 terms
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
stock option financial
"exercised his stock option awarded on April 17, 2023"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Option to Purchase Common Stock financial
"security_title": "Option to Purchase Common Stock""
exercise price financial
"at a price of $33.81 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transactions did AGX executive Charles Edwin Collins IV report?
He reported exercising stock options for 13,568 AGX shares and selling 13,568 shares in open‑market transactions. These moves convert option awards into common stock and then into cash while leaving him with a continuing direct ownership stake.
What stock options did Collins exercise in this Form 4 for AGX?
He exercised options granted in 2020, 2022, 2023, 2024, and 2025, covering 13,568 underlying AGX shares at exercise prices of $33.81, $36.78, $39.47, $61.22, and $148.72 per share, turning these derivative awards into common stock.
What is the overall pattern of Collins’ April 2026 AGX trades?
The filing shows an exercise‑and‑sell pattern. Collins exercised options for 13,568 AGX shares and sold an equal number of shares in the open market, while continuing to hold 30,320 shares directly after the transactions.